These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 1672460

  • 1. NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors.
    Hall H, Högberg T, Halldin C, Köhler C, Ström P, Ross SB, Larsson SA, Farde L.
    Psychopharmacology (Berl); 1991; 103(1):6-18. PubMed ID: 1672460
    [Abstract] [Full Text] [Related]

  • 2. Syntheses of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298), selective ligands for the study of dopamine D-2 receptors.
    Högberg T, Ström P, Hall H, Köhler C, Halldin C, Farde L.
    Acta Pharm Nord; 1990; 2(1):53-60. PubMed ID: 1971177
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H, Högberg T, Halldin C, Bengtsson S, Wedel I.
    Eur J Pharmacol; 1991 Aug 16; 201(1):1-10. PubMed ID: 1686586
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D2 receptors in the rat, monkey and the post-mortem human hippocampus. An autoradiographic study using the novel D2-selective ligand 125I-NCQ 298.
    Köhler C, Ericson H, Högberg T, Halldin C, Chan-Palay V.
    Neurosci Lett; 1991 Apr 15; 125(1):12-4. PubMed ID: 1677461
    [Abstract] [Full Text] [Related]

  • 5. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding.
    Halldin C, Farde L, Högberg T, Hall H, Ström P, Ohlberger A, Solin O.
    Int J Rad Appl Instrum B; 1991 Apr 15; 18(8):871-81. PubMed ID: 1839303
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
    Verhoeff NP, Bobeldijk M, Feenstra MG, Boer GJ, Maas MA, Erdtsieck-Ernste E, de Bruin K, van Royen EA.
    Int J Rad Appl Instrum B; 1991 Apr 15; 18(8):837-46. PubMed ID: 1839302
    [Abstract] [Full Text] [Related]

  • 7. In vitro receptor binding characteristics of the new dopamine D2 antagonist [125I]NCQ-298: methodological considerations of high affinity binding.
    Jerning E, Malmberg A, Mohell N.
    J Recept Signal Transduct Res; 1995 Apr 15; 15(1-4):503-15. PubMed ID: 8903960
    [Abstract] [Full Text] [Related]

  • 8. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM, Ansari MS, Schmidt DE, de Paulis T, Clanton JA, Innis R, al-Tikriti M, Manning RG, Gillespie D.
    Life Sci; 1991 Apr 15; 49(8):617-28. PubMed ID: 1830917
    [Abstract] [Full Text] [Related]

  • 9. Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors.
    Hall H, Halldin C, Jerning E, Osterlund M, Farde L, Sedvall G.
    Nucl Med Biol; 1997 Jul 15; 24(5):389-93. PubMed ID: 9290072
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
    Saji H, Tanahashi K, Kinoshita T, Iida Y, Magata Y, Yokoyama A.
    Nucl Med Biol; 1996 Feb 15; 23(2):121-7. PubMed ID: 8868283
    [Abstract] [Full Text] [Related]

  • 11. Raclopride, a new selective ligand for the dopamine-D2 receptors.
    Hall H, Köhler C, Gawell L, Farde L, Sedvall G.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 Feb 15; 12(5):559-68. PubMed ID: 2975809
    [Abstract] [Full Text] [Related]

  • 12. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
    Malmberg A, Jerning E, Mohell N.
    Eur J Pharmacol; 1996 May 06; 303(1-2):123-8. PubMed ID: 8804920
    [Abstract] [Full Text] [Related]

  • 13. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
    Billings JJ, Kung MP, Chumpradit S, Mozley D, Alavi A, Kung HF.
    J Neurochem; 1992 Jan 06; 58(1):227-36. PubMed ID: 1530770
    [Abstract] [Full Text] [Related]

  • 14. In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.
    Brücke T, Tsai YF, McLellan C, Singhanyom W, Kung HF, Cohen RM, Chiueh CC.
    Life Sci; 1988 Jan 06; 42(21):2097-104. PubMed ID: 3260318
    [Abstract] [Full Text] [Related]

  • 15. Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors.
    Köhler C, Hall H, Gawell L.
    Eur J Pharmacol; 1986 Jan 21; 120(2):217-26. PubMed ID: 3948920
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo characterization of R(+)-FIDA2: a dopamine D2-like imaging agent.
    Vessotskie JM, Kung MP, Chumpradit S, Romaniello G, McElgin W, Frederick D, Malison RT, Kung HF.
    J Nucl Med; 1995 Jul 21; 36(7):1282-8. PubMed ID: 7790957
    [Abstract] [Full Text] [Related]

  • 17. Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.
    Langer O, Halldin C, Dollé F, Swahn CG, Olsson H, Karlsson P, Hall H, Sandell J, Lundkvist C, Vaufrey F, Loc'h C, Crouzel C, Mazière B, Farde L.
    Nucl Med Biol; 1999 Jul 21; 26(5):509-18. PubMed ID: 10473189
    [Abstract] [Full Text] [Related]

  • 18. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain.
    de Paulis T.
    Curr Pharm Des; 2003 Jul 21; 9(8):673-96. PubMed ID: 12570798
    [Abstract] [Full Text] [Related]

  • 19. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
    Köhler C, Hall H, Ogren SO, Gawell L.
    Biochem Pharmacol; 1985 Jul 01; 34(13):2251-9. PubMed ID: 4015674
    [Abstract] [Full Text] [Related]

  • 20. Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography.
    Halldin C, Högberg T, Farde L.
    Nucl Med Biol; 1994 May 01; 21(4):627-31. PubMed ID: 9234320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.